Skeletal disorders

Global Joint Pain Injection Market (2021 to 2028) - COVID-19 Impact and Analysis - ResearchAndMarkets.com

Retrieved on: 
Friday, May 14, 2021
Pharmaceutical, Health, Other Health, Medical specialties, Medicine, Health, Overuse injuries, Elbow, Knee, Injection, Skeletal disorders, Rheumatology, Sports injuries, Osteoarthritis, Tendinopathy

However, the high costs of joint repair therapies hinder the market growth.\nHyaluronic acid injections are usually administered for treating sports injuries, as they aid in pain relief, reduce inflammation, and improve joint function.

Key Points: 
  • However, the high costs of joint repair therapies hinder the market growth.\nHyaluronic acid injections are usually administered for treating sports injuries, as they aid in pain relief, reduce inflammation, and improve joint function.
  • Sports injuries are caused due to direct impact or due to the application of force that is larger than the body part can withstand.
  • Thus, the growing number of sport injuries is boosting the demand for joint pain injections.\nBased on joint type, the joint pain injection market is segmented into knee, shoulder and elbow, hip, foot and ankle, and others.
  • In 2020, the knee joint type segment accounted for the largest share of the market.

Global Ankylosing Spondylitis Market (2021 to 2028) - Share, Size, Trends and Industry Analysis Report - ResearchAndMarkets.com

Retrieved on: 
Friday, May 14, 2021
Health, General Health, Medical specialties, Musculoskeletal system, Clinical medicine, Rheumatology, Skeletal disorders, Spondylitis, Ankylosing spondylitis, Pelvis, Bechterew, Sacroiliac joint, Arthritis, BASDAI

b'The "Ankylosing Spondylitis Market Share, Size, Trends, Industry Analysis Report, By Drug; By Treatment Type; By Regions; Segment Forecast, 2021 - 2028" report has been added to ResearchAndMarkets.com\'s offering.\nThe global ankylosing spondylitis market size is expected to reach USD 8.45 billion by 2028 according to a new study.

Key Points: 
  • b'The "Ankylosing Spondylitis Market Share, Size, Trends, Industry Analysis Report, By Drug; By Treatment Type; By Regions; Segment Forecast, 2021 - 2028" report has been added to ResearchAndMarkets.com\'s offering.\nThe global ankylosing spondylitis market size is expected to reach USD 8.45 billion by 2028 according to a new study.
  • The report gives a detailed insight into current market dynamics and provides analysis on future market growth.\nAnkylosing Spondylitis (AS), also known as Bechterew disease is the rare type of arthritis causing stiffness and intense pain in the individual\'s spine, starting from lower back sacral bones.
  • Ankylosing spondylitis is started from an individual\'s sacroiliac joints, where the spinal cord connects with the pelvic girdle.
  • According to the recent population estimates the prevalence rate of ankylosing spondylitis in the U.S. is around 0.2-0.5 percent and based on market data from multiple countries the global incidence rate stood at 0.4-14 per 100,000 individuals.\n'

Anika to Host its 2021 Virtual Investor Day on June 3, 2021

Retrieved on: 
Thursday, May 13, 2021
Medical specialties, Medicine, Clinical medicine, Skeletal disorders, Orthopedic surgery, Osteoarthritis, Tissue engineering, Arthritis

The event will include presentations followed by a Q&A panel session with senior leadership.

Key Points: 
  • The event will include presentations followed by a Q&A panel session with senior leadership.
  • We partner with physicians to understand what they need most to treat their patients and we develop minimally invasive products that restore active living for people around the world.
  • We are committed to leading in high opportunity spaces within orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair and bone preserving joint technologies.
  • For more information, please visit www.anika.com .\n"

ZetrOZ CEO Discusses Sustained Acoustic Medicine With Medical Devices Group

Retrieved on: 
Wednesday, May 12, 2021
Health, Skeletal disorders, Clinical medicine, Arthritis, Rheumatology, Health Economics

"Waiting over a decade for new breakthroughs is simply unacceptable; there\'s more we can do within the medical community to push these technologies to the forefront and get them into the hands of people that can truly benefit from them.

Key Points: 
  • "Waiting over a decade for new breakthroughs is simply unacceptable; there\'s more we can do within the medical community to push these technologies to the forefront and get them into the hands of people that can truly benefit from them.
  • Providers are often unwilling to cover the costs of new innovations.
  • Many expect to see extensive doctor utilization before they will start paying for a new treatment.
  • ZetrOZ Systems produced UltrOZ, samSport and samPro 2.0 to provide safe and effective treatment options for prevalent conditions such as arthritis.

Treace to Announce Interim Results from ALIGN3D™ at ACFAS 2021

Retrieved on: 
Wednesday, May 12, 2021
Skeletal disorders, Foot diseases, Bunion, Valgus deformity, Clinical medicine, Valgus, Syndesmosis procedure

The study will evaluate for consistent and reliable correction of all three dimensions of the bunion deformity with the Lapiplasty\xc2\xae Procedure, as well as maintenance of such correction following accelerated return to weight-bearing.

Key Points: 
  • The study will evaluate for consistent and reliable correction of all three dimensions of the bunion deformity with the Lapiplasty\xc2\xae Procedure, as well as maintenance of such correction following accelerated return to weight-bearing.
  • The primary effectiveness endpoint is radiographic recurrence of the hallux valgus deformity at 24 months follow up.
  • The study enrolled 173 patients, aged 14 to 58 years, at 7 clinical sites in the United States with 13 participating surgeons.
  • Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot.

Worldwide Osteoarthritis Industry (2021 to 2035) - Identify Patient Sub-groups - ResearchAndMarkets.com

Retrieved on: 
Wednesday, May 12, 2021
Health, General Health, Skeletal disorders, Medical specialties, Arthritis, Clinical medicine, Medicine, Rheumatology, Osteoarthritis, Aging-associated diseases

b'The "Global Osteoarthritis Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nThis research report provides Osteoarthritis epidemiology, demographics, and patient flow.

Key Points: 
  • b'The "Global Osteoarthritis Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nThis research report provides Osteoarthritis epidemiology, demographics, and patient flow.
  • The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.\nThe research provides population data to characterize Osteoarthritis patients, history of the disease at the population level (Osteoarthritis prevalence, Osteoarthritis incidence) and at the clinical level (from diagnosis to treated patients).
  • It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.\nDemographics: Osteoarthritis patients by age group, gender\nThe data from this research will help executives:\nEstablish basis for Osteoarthritis market sizing, assessing market potential, and developing drug forecast models\nIdentify Osteoarthritis patients segments through age groups, gender, and disease sub-types\n'

Arthritis National Research Foundation Awards 18 New Research Grants

Retrieved on: 
Thursday, May 6, 2021
Philanthropy, Health, Other Health, Managed care, Foundation, Research, Science, Medical specialties, Medicine, Clinical medicine, Rheumatology, Autoimmune diseases, Connective tissue diseases, Arthritis, Skeletal disorders, Autoimmunity, Childhood arthritis, Rheumatoid arthritis, Autoimmune disease

b'The Arthritis National Research Foundation (ANRF) is proud to announce the awarding of 18 new research grants to scientists across the U.S. with bold new ideas for the treatment of arthritis and related autoimmune conditions.

Key Points: 
  • b'The Arthritis National Research Foundation (ANRF) is proud to announce the awarding of 18 new research grants to scientists across the U.S. with bold new ideas for the treatment of arthritis and related autoimmune conditions.
  • Ultimately, they selected 18 projects that could represent the future of diagnostics and treatments across the spectrum of autoimmune diseases.
  • These include Rheumatoid Arthritis, Juvenile Arthritis, Spondylarthritis, Osteoarthritis, Lupus, Scleroderma, and infection-induced autoimmunity in COVID-19 patients.
  • This commitment is shared by our community of individual supporters and bolstered by new industry partnerships.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210506005200/en/\n'

CBDMEDIC™ Announces Partnership With U.S. Women's and Olympic Soccer Star, Carli Lloyd

Retrieved on: 
Wednesday, May 5, 2021
Branches of biology, Acute pain, Clinical medicine, Medicine, Skeletal disorders, Arthritis, Rheumatology, Pain

Lloyd partnered with CBDMEDIC after beginning to use its safe and effective topical CBD products following a knee injury and surgery last year.

Key Points: 
  • Lloyd partnered with CBDMEDIC after beginning to use its safe and effective topical CBD products following a knee injury and surgery last year.
  • Lloyd attributes her use of CBDMEDIC as a key factor in her recovery.\n"Taking care of and listening to our bodies is extremely important, especially when it comes to pain relief," said Lloyd.
  • "\nDuring her recovery, Lloyd began using CBDMEDIC topical products, including Active Sport Pain Relief Ointment and Active Sport Pain Relief Stick, which offer temporary relief of sore muscles.
  • She also applies CBDMEDIC Arthritis Aches and Pain Relief Cream, which is effective in relieving joint pain and stiffness.

Paragon 28, Inc. Receives FDA Clearance and Successfully Completes First MAVEN™ Patient-Specific Instrumentation Surgery

Retrieved on: 
Tuesday, May 4, 2021
Medical specialties, Medicine, Clinical medicine, Skeletal disorders, Apache Maven, Arthritis, CT scan, Scan, Maven Huffman, MAVEN

MAVEN PSI is compatible with both weight-bearing CT and traditional CT scanning technologies and features one continuous scan from the knee through the base of the foot to capture biomechanically accurate data.

Key Points: 
  • MAVEN PSI is compatible with both weight-bearing CT and traditional CT scanning technologies and features one continuous scan from the knee through the base of the foot to capture biomechanically accurate data.
  • The System introduces a perfect blend of performance and reliability.
  • MAVEN PSI also allows for refined intra-operative positioning and micro adjustments if necessary.
  • With this comprehensive portfolio, Paragon 28 provides its customers innovative ankle solutions for trauma, arthritis, and limbsalvage.\nView original content to download multimedia: http://www.prnewswire.com/news-releases/paragon-28-inc-receives-fda-clea...\n'

Anika to Participate in Upcoming Virtual Investor Conferences

Retrieved on: 
Tuesday, May 4, 2021
Medical specialties, Medicine, Clinical medicine, Skeletal disorders, Arthritis, Osteoarthritis, Orthopedic surgery, Tissue engineering

We partner with clinicians to understand what they need most to treat their patients and we develop minimally invasive products that restore active living for people around the world.

Key Points: 
  • We partner with clinicians to understand what they need most to treat their patients and we develop minimally invasive products that restore active living for people around the world.
  • We are committed to leading in high opportunity spaces within orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair and bone preserving joint technologies.
  • Anika is headquartered in Massachusetts with operations in the United States and Europe.
  • For more information about Anika, please visit www.anika.com .\n'